References: Principles of opioid use in palliative care

Hadley G, Derry S, Moore RA, Wiffen PJ. Transdermal fentanyl for cancer pain. Cochrane Database Syst Rev 2013;(10):CD010270. https://www.ncbi.nlm.nih.gov/pubmed/24096644
Heiskanen T, Matzke S, Haakana S, Gergov M, Vuori E, Kalso E. Transdermal fentanyl in cachectic cancer patients. Pain 2009;144(1-2):218-22. https://www.ncbi.nlm.nih.gov/pubmed/19442446
Palliative Care Australia (PCA). Sustainable access to prescription opioids for use in palliative care. Position statement. Canberra: PCA; 2019. Accessed 8 December 2022. https://palliativecare.org.au/mediarelease/future-proofing-sustainable-access-to-prescription-opioids-to-relieve-suffering/
Tassinari D, Sartori S, Tamburini E, Scarpi E, Raffaeli W, Tombesi P, et al. Adverse effects of transdermal opiates treating moderate-severe cancer pain in comparison to long-acting morphine: a meta-analysis and systematic review of the literature. J Palliat Med 2008;11(3):492-501. https://www.ncbi.nlm.nih.gov/pubmed/18363493